ArticleBMC infectious diseases2025
The prevalence of nine human herpesviruses in urogenital samples from young women in Finland.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Co-Occurrence of High-Risk Human Papillomavirus and Herpesviruses Infections in Female Kidney Transplant Recipients: A Prospective One-Year Study.Medicina (Kaunas, Lithuania) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBeyond herpes simplex virus (HSV), the pathogenic role and occurrence of other human herpesviruses (HHVs) in the genitourinary tract remain largely unclear. This study aimed to determine the prevalence and level of shedding of nine typical human-infecting herpesviruses in genitourinary specimens of young women.
methodsWe investigated the prevalence and quantity of HHVs using qPCR in urogenital samples from 380 women participating in a community-randomized human papillomavirus (HPV) vaccination trial and in a randomized trial on the effectiveness of Chlamydia trachomatis screening.
resultsThe prevalence of Epstein-Barr virus (EBV) DNA was the most frequent finding (8.4% positive). Other herpesvirus DNA was detected less frequently: HHV-6B in 5.8%, cytomegalovirus (CMV) in 3.7%, HHV-7 in 1.6%, HSV-2 in 0.8%, and HSV-1 in 0.5% of the specimens. The varicella-zoster virus (VZV), HHV-6A, and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) DNA were not detected in any of the samples. Additionally, the prevalence of EBV DNA was significantly higher among women who tested positive for C. trachomatis based on a nucleic acid amplification test (NAAT) compared to those who tested negative (11.3% vs. 5.7%, p = 0.049). Similarly, EBV DNA was detected more frequently in women with DNA from sexually transmitted microbes in their samples (C. trachomatis, Mycoplasma genitalium, HPV, or HSV), with a prevalence of 11.4% compared to 4.0% (p = 0.0132).
conclusionsThe increased prevalence of EBV DNA among young women with a sexually transmissible pathogen coinfection suggests more frequent shedding of EBV DNA among those with a sexually transmitted infection and likely higher sexual risk-taking behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.